Dual antiplatelet Tx for stroke prevention: Worth the risk?
Here's what the evidence tells us about the use of 2 regimens-clopidogrel + aspirin and ER dipyridamole + aspirin-to prevent secondary ischemic stroke.
| Publicado en: | Journal of Family Practice Vol. 69; no. 6; pp. 272 - 280 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Frontline Medical Communications
Jul2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144795784&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 144795784 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00943509 JFP jtl: Journal of Family Practice issn: 00943509 maglogo: N pubinfo: dt: Jul2020 vid: 69 iid: 6 pid: 11942 pub: Frontline Medical Communications place: Newark, New Jersey artinfo: ui: 144795784 144795784 NLM32724907 NLM32724907 144795784 ppf: 272 ppct: 8 formats: tig: atl: Dual antiplatelet Tx for stroke prevention: Worth the risk? aug: au: Helmer, Robert S. Helmer, Allison M. Smithgall, Sean affil: Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Mobile, AL sug: subj: Stroke Drug Therapy Drug Therapy, Combination Standards Platelet Aggregation Inhibitors Adverse Effects Stroke Prevention and Control Risk Assessment Methods Platelet Aggregation Inhibitors Therapeutic Use Aspirin Therapeutic Use Platelet Aggregation Inhibitors Pharmacodynamics Drug Therapy, Combination Statistics and Numerical Data Aspirin Adverse Effects Drug Therapy, Combination Methods Aspirin Pharmacodynamics Scales ab: Here's what the evidence tells us about the use of 2 regimens-clopidogrel + aspirin and ER dipyridamole + aspirin-to prevent secondary ischemic stroke. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|